Literature DB >> 18432761

Enzyme-linked immunosorbent assays.

P Hornbeck1.   

Abstract

This unit describes six different ELISA systems for the detection of specific antibodies, soluble antigens, or cell-surface antigens. In all six systems, soluble reactants are removed from solution after specifically binding to solid-phase reactants. In the first four protocols, solid-phase reactants are prepared by adsorbing an antigen or antibody onto plastic microtiter plates; in the next two protocols, the solid-phase reactants are cell-associated molecules. In all protocols, the solid-phase reagents are incubated with secondary or tertiary reactants covalently coupled to an enzyme. Unbound conjugates are washed out and a chromogenic or fluorogenic substrate is added. As the substrate is hydrolyzed by the bound enzyme conjugate, a colored or fluorescent product is generated. Finally, the product is detected visually or with a microtiter plate reader. The amount of product generated is proportional to the amount of analysate in the test mixture. The Support Protocol can be used to optimize the different ELISAs. The second support protocol presents a method for preparing alkaline phosphatase conjugates.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 18432761     DOI: 10.1002/0471142735.im0201s01

Source DB:  PubMed          Journal:  Curr Protoc Immunol        ISSN: 1934-3671


  9 in total

Review 1.  Multi-Dimensional Nanostructures for Microfluidic Screening of Biomarkers: From Molecular Separation to Cancer Cell Detection.

Authors:  Elaine Ng; Kaina Chen; Annie Hang; Abeer Syed; John X J Zhang
Journal:  Ann Biomed Eng       Date:  2015-12-21       Impact factor: 3.934

2.  Lipocalin 2 is required for pulmonary host defense against Klebsiella infection.

Authors:  Yvonne R Chan; Jessica S Liu; Derek A Pociask; Mingquan Zheng; Timothy A Mietzner; Thorsten Berger; Tak W Mak; Matthew C Clifton; Roland K Strong; Prabir Ray; Jay K Kolls
Journal:  J Immunol       Date:  2009-04-15       Impact factor: 5.422

3.  Immunization with a novel chimeric peptide representing B and T cell epitopes from HER2 extracellular domain (HER2 ECD) for breast cancer.

Authors:  Manijeh Mahdavi; Mehrnaz Keyhanfar; Abbas Jafarian; Hassan Mohabatkar; Mohammad Rabbani
Journal:  Tumour Biol       Date:  2014-08-21

4.  Clinical efficacy and safety of crizotinib and alectinib in ALK-positive non-small cell lung cancer treatment and predictive value of CEA and CA125 for treatment efficacy.

Authors:  Zhi Li; Jun Zhao
Journal:  Am J Transl Res       Date:  2021-11-15       Impact factor: 4.060

5.  A lysine-rich motif in the phosphatidylserine receptor PSR-1 mediates recognition and removal of apoptotic cells.

Authors:  Hengwen Yang; Yu-Zen Chen; Yi Zhang; Xiaohui Wang; Xiang Zhao; James I Godfroy; Qian Liang; Man Zhang; Tianying Zhang; Quan Yuan; Mary Ann Royal; Monica Driscoll; Ning-Shao Xia; Hang Yin; Ding Xue
Journal:  Nat Commun       Date:  2015-01-07       Impact factor: 14.919

6.  Protein Discrimination Using a Fluorescence-Based Sensor Array of Thiacarbocyanine-GUMBOS.

Authors:  Rocío L Pérez; Mingyan Cong; Stephanie R Vaughan; Caitlan E Ayala; Waduge Indika S Galpothdeniya; John K Mathaga; Isiah M Warner
Journal:  ACS Sens       Date:  2020-08-03       Impact factor: 7.711

7.  Development of a highly sensitive enzyme-linked immunosorbent assay (ELISA) through use of poly-protein G-expressing cell-based microplates.

Authors:  Yi-Jou Chen; Michael Chen; Yuan-Chin Hsieh; Yu-Cheng Su; Chang-Hung Wang; Chiu-Min Cheng; An-Pei Kao; Kai-Hung Wang; Jing-Jy Cheng; Kuo-Hsiang Chuang
Journal:  Sci Rep       Date:  2018-12-14       Impact factor: 4.379

8.  Pre-evaluation of humoral immune response of Bactrian camels by the quantification of Th2 cytokines using real-time PCR.

Authors:  Xinyu Yu; Yuan Wu; Jiarong Zhang; Azhati Zulipikaer; Jin Chen
Journal:  J Biomed Res       Date:  2020-01-23

9.  Highly enhanced ELISA sensitivity using acetylated chitosan surfaces.

Authors:  Tania García-Maceira; Fé I García-Maceira; José A González-Reyes; Elier Paz-Rojas
Journal:  BMC Biotechnol       Date:  2020-08-19       Impact factor: 2.563

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.